Alterity Therapeutics (ASX:ATH) – Webinar Presentation
David Stamler - CEO - Alterity Therapeutics (ASX:ATH) is a clinical-stage biotechnology company dedicated to creating an alternate future for people living with neurodegenerative diseases.
Read More